Gesamtlänge aller Episoden: 6 days 19 hours 18 minutes
Interview with Kristin, 18 year old teen living with mitochondrial disease
Dr. Alex Flores speaks about gastrointestinal issues for mitochondrial disease patients.
This month MitoAction welcomed Dr. Fran Kendall of Emory University's Department of Human Genetics mitochondrial program to discuss the dosing debate around CoQ10 and creatine.
Exclusive Interview with Dr. Guy Miller, CEO of Edison Pharma. On July 15, 2008 Edison Pharma and partner Penwest Pharmaceuticals announced that A0001, an "improved" variant of Coenzyme Q10 (CoQ10), has entered Phase 1 clinical development with healthy volunteers. Edison predicts trials in patients with inherited mitochondrial disease will begin in 2009.